Inovio Pharmaceuticals
INO
INO
208 hedge funds and large institutions have $428M invested in Inovio Pharmaceuticals in 2021 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 62 increasing their positions, 63 reducing their positions, and 38 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
208
Holders Change
-5
Holders Change %
-2.35%
% of All Funds
3.21%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
34
Increased
62
Reduced
63
Closed
38
Calls
$15.5M
Puts
$18.2M
Net Calls
-$2.67M
Net Calls Change
+$4.22M
Top Buyers
| 1 |
State Street
Boston,
Massachusetts
|
$66.4M |
| 2 |
D.E. Shaw & Co
New York
|
$29.9M |
| 3 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
$24.6M |
| 4 |
Rafferty Asset Management
New York
|
$6.15M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
$3.21M |
